Deciphering Carbapenemase Gene Transmission in Carbapenem-Resistant Enterobacter cloacae: Insights from a Multicenter Guangdong Study

Study Background and Research Question

Carbapenem-resistant Enterobacter cloacae (CREC) has emerged as a major clinical challenge, complicating infection management worldwide. The COVID-19 pandemic has further intensified antimicrobial resistance threats, owing to increased antibiotic consumption and healthcare disruptions. Despite prior surveillance of carbapenem-resistant Enterobacteriaceae (CRE), granular data on the molecular characteristics and transmission dynamics of carbapenemase-encoding genes (CEGs) in CREC remain sparse in China. Chen et al. (2025) set out to bridge this knowledge gap by systematically characterizing CEGs in CREC isolates collected from eight teaching hospitals in Guangdong Province between December 2022 and June 2024 (paper).

Key Innovation from the Reference Study

This study is distinguished by its comprehensive approach to mapping both the prevalence and mobility of CEGs—namely, blaNDM-1, blaIMP, and blaKPC-2—within a multicenter clinical cohort. Notably, the research provides direct evidence for the high rates of plasmid-mediated horizontal transfer of these resistance determinants, documenting a 95.65% conjugation success rate among CEG-positive isolates (paper). The integration of variable temperature SDS plasmid curing, PCR, conjugation assays, and ERIC-PCR genotyping enables a nuanced understanding of both genetic and epidemiological patterns underlying CREC dissemination.

Methods and Experimental Design Insights

The researchers curated a panel of 54 non-redundant CREC isolates spanning diverse departments and specimen types from eight hospitals. The core methodological elements included:

• Detection of CEGs: PCR screening targeted blaNDM-1, blaIMP, and blaKPC-2 genes across chromosomal and plasmid DNA.
• Plasmid Elimination and Localization: Variable temperature SDS treatment allowed for discrimination between chromosomal and plasmid-encoded resistance.
• Conjugation Experiments: Filter-mating assays assessed horizontal transferability of CEGs into recipient strains, tracked via antibiotic selection.
• Genotyping: ERIC-PCR fingerprinting and NTSYS clustering defined the genetic relatedness of isolates, revealing clonal and polyclonal dissemination.
• Antimicrobial Susceptibility Testing: The broth microdilution method quantified resistance profiles relative to CEG carriage.
• Mobile Genetic Element Analysis: Six distinct transposon/integron types were mapped, spotlighting ISEcp1 as most prevalent (87.04% of strains).

Such a multidimensional strategy enabled the authors to dissect both the molecular underpinnings and epidemiological trends of resistance gene spread (paper).

Protocol Parameters

• plasmid selection assay | 25–170 μg/mL chloramphenicol | selection for stringent/relaxed plasmids | Enables discrimination of plasmid-bearing strains in conjugation and curing experiments | product_spec
• protein synthesis inhibition | ≥25 μg/mL chloramphenicol | functional inhibition in Enterobacteriaceae | Used to suppress background growth and confirm acquisition of resistance elements | workflow_recommendation
• antimicrobial susceptibility testing | Broth microdilution with standard antibiotic panels | all clinical CREC isolates | Determines phenotypic consequences of CEG carriage | paper
• PCR detection of CEGs | Standard primer sets, thermal cycling | chromosomal and plasmid DNA templates | Sensitive and specific identification of resistance genes | paper

Core Findings and Why They Matter

The investigation yielded several pivotal results:

• High Prevalence of CEGs: 85.19% (46/54) of CREC isolates harbored carbapenemase-encoding genes (paper).
• Dominance of blaNDM-1: The blaNDM-1 gene was found on both chromosomes and plasmids in 33.33% of isolates, and exclusively on plasmids in 46.30%—underscoring the gene’s mobility and epidemiological significance.
• Efficient Horizontal Transfer: Conjugation assays demonstrated that 95.65% of CEGs could be transferred, with blaNDM-1 and blaIMP genes showing particularly high rates (95.45% and 100%, respectively).
• Multidrug Resistance Phenotype: CEG-positive isolates exhibited markedly elevated resistance rates to imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin, and levofloxacin compared to CEG-negative strains (P < 0.05).
• Mobile Genetic Elements: Six types of MGEs were detected, with ISEcp1 present in 87.04% of CREC isolates, facilitating gene mobilization.
• Genetic Diversity and Epidemiology: The 54 CREC isolates were categorized into 17 genotypes, with two major types (E and G) accounting for over 40% of strains and being distributed across multiple hospitals and departments. Higher detection rates were observed in males, elderly patients, respiratory departments, and sputum samples.

These findings collectively illustrate a scenario where multidrug-resistant CREC, dominated by mobile blaNDM-1, can spread both clonally and horizontally, presenting formidable infection control challenges (paper).

Comparison with Existing Internal Articles

Several internal resources provide context for molecular biology tools relevant to studies of resistance gene dynamics:

• The article "Chloramphenicol: Mechanisms, Applications, and Research Boundaries" details the mechanistic rationale for using chloramphenicol as a bacterial protein synthesis inhibitor and its role in plasmid selection assays. The reference study’s use of conjugation and plasmid elimination aligns closely with these applications, as chloramphenicol enables selection of transconjugants and cured isolates (internal_article).
• "Chloramphenicol as a Cornerstone in Translational Antimicrobial Research" (internal_article) further explores the implications of using high-purity antibiotic reagents for reproducible resistance gene studies, a theme echoed in the study’s emphasis on molecular rigor.
• The internal study "Transmission Dynamics of Carbapenem-Resistance in E. cloacae" provides a focused epidemiological overview of similar CEG trends in a comparable setting, reinforcing the current study’s findings on the dominance of blaNDM-1 and the role of mobile elements in resistance dissemination.

Together, these resources frame the reference study within a broader experimental toolkit, highlighting the critical role of bacterial protein synthesis inhibitors such as chloramphenicol in molecular epidemiology workflows.

Limitations and Transferability

While the study offers robust molecular and epidemiological data, several limitations merit consideration. The sample size, though multicenter, is regionally restricted and may not capture the full genetic diversity present across China or globally. Phenotypic resistance was measured using standard antibiotic panels, but the potential for novel or cryptic resistance mechanisms remains. Furthermore, the study’s temporal window—set during the COVID-19 pandemic—may reflect atypical antibiotic usage patterns.

Nevertheless, the workflow—including PCR-based CEG detection, conjugation assays, and plasmid selection using protein synthesis inhibitors—is broadly transferable to other Enterobacteriaceae and resistance contexts, provided local resistance determinants and epidemiology are considered (internal_article).

Research Support Resources

Researchers aiming to reproduce or extend such resistance gene transmission studies can leverage high-purity reagents for reliable results. For instance, Chloramphenicol (2,2-dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide, SKU: A2512) is widely used as a stringent selection agent in plasmid transfer and elimination assays, as well as for protein synthesis inhibition in molecular biology research. Its application aligns with the methods employed in this study and is supported by internal benchmarking for reproducibility and purity (workflow_recommendation).